Nukkleus DFNS
Nukkleus Q2 FY25: revenue $0; diluted EPS $0.54
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001213900-25-076794
- Document
- 10-Q
- Exhibit 10.1
- Form of exchange warrant - August 2025
- Exhibit 10.2
- Form of pre-funded warrant - August 2025
Key figures from this report
These are the numbers Nukkleus reported for Q2 FY25, the quarter ended Jun 30, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$0−100% from $175K in Q3 FY2410-Q income statement, on EDGAR
- Net income$3.0MAgainst −$1.6M in Q3 FY2410-Q income statement, on EDGAR
- Diluted EPS$0.54Against −$0.11 in Q3 FY2410-Q income statement, on EDGAR
- Cash and cash equivalents$1.5M+24658% from $6K in Q3 FY2410-Q balance sheet, on EDGAR
- Cash from operations−$1.4MAgainst −$698K in Q3 FY2410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 8742 and related industry codes: the same peer list as the financial tables.
- GenFlat Holdings GFLT public float $39M, Dec 31, 2025
- ACCESS Newswire ACCS public float $48M, Jun 30, 2025
- CISO Global CISO public float $32M, Jun 30, 2025
- Mastech Digital MHH public float $25M, Jun 30, 2025
- Nordicus Partners NORD public float $21M, Sep 30, 2025